Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Liabilities and Shareholders Equity (2018 - 2026)

Health Catalyst filings provide 9 years of Liabilities and Shareholders Equity readings, the most recent being $412.2 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 53.77% to $412.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.1 billion, a 34.93% decrease, with the full-year FY2025 number at $502.6 million, down 41.48% from a year prior.
  • Liabilities and Shareholders Equity hit $412.2 million in Q1 2026 for Health Catalyst, down from $502.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $891.5 million in Q1 2025 to a low of $412.2 million in Q1 2026.
  • Median Liabilities and Shareholders Equity over the past 5 years was $722.9 million (2023), compared with a mean of $713.1 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 44.41% in 2022 and later tumbled 53.77% in 2026.
  • Health Catalyst's Liabilities and Shareholders Equity stood at $752.3 million in 2022, then dropped by 6.71% to $701.8 million in 2023, then grew by 22.39% to $858.9 million in 2024, then tumbled by 41.48% to $502.6 million in 2025, then fell by 17.99% to $412.2 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $412.2 million (Q1 2026), $502.6 million (Q4 2025), and $587.1 million (Q3 2025) per Business Quant data.